Chytra V Anand

Learn More
Traditionally, the enzyme myeloperoxidase (MPO) was almost exclusively associated with the phenomenon of innate immunity. For almost a century, most of the studies that were carried out on this enzyme were directed towards elucidating the intricate biochemical mechanisms involved in bacterial killing [1]. The unique ability of this enzyme to generate the(More)
End stage renal disease (ESRD) patients on hemodialysis (HD) have an increased oxidative stress, with a high risk of atherosclerosis and other co-morbid conditions. Recent studies have suggested that myeloperoxidase (MPO)—mediated oxidative stress may play a role in the pathogenesis of cardiovascular complications in dialysis patients. Furthermore, dialysis(More)
  • 1